With its newest $1 billion deal with Marina Oncology, Novartis moves one step cl...
Roughly one in every 12 pregnancies is estimated to be affected by preeclampsia,...
Enhancing the quality of weight loss is the next area of focus for pharmaceutica...
Harmony Biosciences has successfully acquired Epygenix along with its late-stage...
The Food and Drug Administration (FDA) has just greenlighted Pfizer’s gene thera...
The add-on medication for schizophrenia developed by Newron Pharmaceuticals was ...
A new commercial player for rare diseases has entered the market with the approv...
AriBio has achieved a crucial milestone in the development of its preclinical or...
Bristol Myers Squibb has invested $65 million in Repertoire Immune Medicines, be...
The Alternative Methods Advancement Project (AMAP) by Charles River Laboratories...
The CDC and the FDA US began a joint investigation to stop the distribution of c...
Within the context of AbbVie’s $8.7 billion acquisition of Cerevel Therapeutics ...
The FDA has halted a phase 1 trial of Neumora Therapeutics’ treatment for schizo...
Platelets are always in low supply with an additional problem with these sticky ...
Microbiome biotech MaaT Pharma says it will market its pooled fecal treatment me...
The FDA has placed Neumora’s schizophrenia medication on hold due to reports of ...
